Literature DB >> 10887307

Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study.

R Y Lin1, L B Schwartz, A Curry, G R Pesola, R J Knight, H S Lee, L Bakalchuk, C Tenenbaum, R E Westfal.   

Abstract

BACKGROUND: Emergency department visits for acute allergic reactions are common. Although the diagnosis and classification of these allergic reactions is primarily empiric, it is not always clear whether certain signs and symptoms constitute systemic mediator release syndromes, such as anaphylaxis, and thus may warrant more aggressive therapy or follow-up.
OBJECTIVE: We sought to determine associations between various clinical signs and symptoms with both plasma histamine levels and serum tryptase levels in adult patients presenting to an emergency department with acute allergic syndromes. The clinical correlates of raised beta-tryptase levels were also investigated.
METHODS: Ninety-seven adult emergency department patients were prospectively studied by using a questionnaire, physical examination, and serum-plasma sampling. Plasma histamine and serum total and beta-tryptase levels were determined. Clinical groupings were compared for mediator levels by using simple and multivariate analysis.
RESULTS: Elevated levels of plasma histamine (>10 nmol/L) and serum total tryptase (>15 ng/mL) were observed in 42 and 20 patients, respectively. Detectable beta-tryptase (>/=1 ng/mL) was observed in 23 patients, including 15 of the patients with elevated total tryptase levels. Suspected food allergy incidences and the duration of reaction were similar in patients with increased histamine levels and in patients with increased tryptase levels. Increased total tryptase levels, histamine levels, or both were observed in some patients who did not have airway, cardiovascular, or abdominal signs. Histamine levels correlated better with clinical signs than tryptase levels. Histamine elevations (>10 nmol/L) were observed more frequently in patients characterized by the following clinical signs in univariate analysis: the presence of urticaria, more extensive erythema, abnormal abdominal findings, and wheezing. Total tryptase increases were observed more frequently only in patients with urticaria. Histamine levels correlated with initial heart rates. In multivariate analysis the extent of urticaria was the best single predictor of plasma histamine levels and of either an elevated histamine or tryptase level. Detectable beta-tryptase levels were observed in some patients who had neither elevated total tryptase nor elevated histamine levels. Unlike patients without detectable beta-tryptase levels, patients who had detectable beta-tryptase levels had a significant correlation between total tryptase and histamine levels (P <.05).
CONCLUSIONS: Raised histamine and, less commonly, raised tryptase levels are observed in almost 50% of patients presenting to emergency departments with acute allergic reactions. Some cases associated with systemic mediator release do not have classical features of severe anaphylaxis, such as hypotension or tachycardia. The lack of total tryptase elevations in many patients with elevated plasma histamine levels suggests basophil involvement. The clinical utility of beta-tryptase determinations in the evaluation of acute allergic reactions needs further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887307     DOI: 10.1067/mai.2000.107600

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  52 in total

Review 1.  Mediators released during human anaphylaxis.

Authors:  Shelley F Stone; Simon G A Brown
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

Review 2.  Mast Cells and Anaphylaxis.

Authors:  Phil Lieberman; Lene Heise Garvey
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 3.  Current and future therapies for the treatment of histamine-induced angioedema.

Authors:  Christine James; Jonathan A Bernstein
Journal:  Expert Opin Pharmacother       Date:  2017-01-25       Impact factor: 3.889

Review 4.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

5.  Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis.

Authors:  Eldad A Hod; Set A Sokol; James C Zimring; Steven L Spitalnik
Journal:  Int J Clin Exp Pathol       Date:  2008-05-30

Review 6.  [Anaphylaxis in childhood and adolescence].

Authors:  H Ott; S Lehmann; G Wurpts; H-F Merk; A Viardot-Helmer; E Rietschel; J M Baron
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

7.  Fatal asthma or anaphylaxis?

Authors:  J Rainbow; G J Browne
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

8.  Mast cells are required for experimental oral allergen-induced diarrhea.

Authors:  Eric B Brandt; Richard T Strait; Dan Hershko; Quan Wang; Emily E Muntel; Troy A Scribner; Nives Zimmermann; Fred D Finkelman; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Navigating the updated anaphylaxis parameters.

Authors:  Stephen F Kemp
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

10.  Peanut allergy: an overview.

Authors:  Nasser Al-Ahmed; Shirina Alsowaidi; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.